A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus‐like particles

Summary Plant expression systems based on nonreplicating virus‐based vectors can be used for the simultaneous expression of multiple genes within the same cell. They therefore have great potential for the production of heteromultimeric protein complexes. This work describes the efficient plant‐based...

Full description

Saved in:
Bibliographic Details
Published inPlant biotechnology journal Vol. 11; no. 7; pp. 839 - 846
Main Authors Thuenemann, Eva C., Meyers, Ann E., Verwey, Jeanette, Rybicki, Edward P., Lomonossoff, George P.
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.09.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Plant expression systems based on nonreplicating virus‐based vectors can be used for the simultaneous expression of multiple genes within the same cell. They therefore have great potential for the production of heteromultimeric protein complexes. This work describes the efficient plant‐based production and assembly of Bluetongue virus‐like particles (VLPs), requiring the simultaneous expression of four distinct proteins in varying amounts. Such particles have the potential to serve as a safe and effective vaccine against Bluetongue virus (BTV), which causes high mortality rates in ruminants and thus has a severe effect on the livestock trade. Here, VLPs produced and assembled in Nicotiana benthamiana using the cowpea mosaic virus–based HyperTrans (CPMV‐HT) and associated pEAQ plant transient expression vector system were shown to elicit a strong antibody response in sheep. Furthermore, they provided protective immunity against a challenge with a South African BTV‐8 field isolate. The results show that transient expression can be used to produce immunologically relevant complex heteromultimeric structures in plants in a matter of days. The results have implications beyond the realm of veterinary vaccines and could be applied to the production of VLPs for human use or the coexpression of multiple enzymes for the manipulation of metabolic pathways.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1467-7644
1467-7652
DOI:10.1111/pbi.12076